A randomized controlled trial of Licartin for preventing hepatoma recurrence after liver transplantation.
Xu J, Shen ZY, Chen XG, Zhang Q, Bian HJ, Zhu P, Xu HY, Song F, Yang XM, Mi L, Zhao QC, Tian R, Feng Q, Zhang SH, Li Y, Jiang JL, Li L, Yu XL, Zhang Z, Chen ZN.
Xu J, et al. Among authors: zhao qc.
Hepatology. 2007 Feb;45(2):269-76. doi: 10.1002/hep.21465.
Hepatology. 2007.
PMID: 17256759
Clinical Trial.